Jiafei Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiafei Chen has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Jing Li
Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China
2 shared publications - Wei Chen
T Magnetic Resonance Translational Medicine Research Center, Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China
2 shared publications - Chao He1 shared publication
Chuanghui Zhou
Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China
1 shared publicationChunlun Xiao
Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China
1 shared publication- Hao-Lei Bai
Department of Physiology, Institute of Brain and Intelligence, Third Military Medical University, Chongqing 400038, China
1 shared publication
Latest Publications
- Open Access
- 9 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (20) , 3270
Non-Invasive Assessment of SMAD4 Expression Status in Pancreatic Ductal Adenocarcinoma: Diagnostic Value of T1ρ-Weighted Imaging Combined with Clinical Parameters
Background/Objectives: Pancreatic ductal adenocarcinoma (PDAC) is a malignancy with poor prognosis, where SMAD4 protein loss is closely associated with increased tumor aggressiveness and metastatic potential. Current assessment of SMAD4 expression relies on IHC of tumor tissue obtained by biopsy or resection, in which limited sampling may not represent intratumoral heterogeneity. T1ρ-weighted imaging, an emerging functional MRI technique, shows promise in characterizing tumor microstructural properties. This study aimed to evaluate the value of T1ρ imaging combined with conventional MRI sequences and clinical parameters for non-invasive prediction of SMAD4 protein expression status in PDAC. Methods: This retrospective single-center study included 57 patients with histologically confirmed PDAC who underwent pretreatment MRI with T1ρ imaging between September 2024 and May 2025. Immunohistochemical analysis revealed SMAD4 intact in 28 tumors (49.1%) and SMAD4 loss in 29 tumors (50.9%). T1ρ values were measured and compared between SMAD4 intact and SMAD4 loss tumors. A multiparametric predictive model incorporating T1ρ values, lymph node metastasis status, and carbohydrate antigen 19-9 (CA19-9) levels was developed. Results: SMAD4 intact tumors demonstrated significantly higher T1ρ values compared to SMAD4 loss tumors (96.34 ± 14.12 vs. 71.93 ± 10.24 ms, p < 0.001). T1ρ achieved an AUC of 0.901 (95% CI: 0.817–0.986), with 82.14% sensitivity and 89.66% specificity, for predicting SMAD4 expression status. A multiparametric model combining T1ρ values, lymph node metastasis status, and CA19-9 levels yielded a numerically higher AUC of 0.932 (95% CI: 0.862–1.000), although the difference from T1ρ alone was not statistically significant (DeLong test, p > 0.05). Conclusions: T1ρ imaging showed potential for predicting SMAD4 status in PDAC.
- 9 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (20) , 3270
Open AccessNon-Invasive Assessment of SMAD4 Expression Status in Pancreatic Ductal Adenocarcinoma: Diagnostic Value of T1ρ-Weighted Imaging Combined with Clinical Parameters
Background/Objectives: Pancreatic ductal adenocarcinoma (PDAC) is a malignancy with poor prognosis, where SMAD4 protein loss is closely associated with increased tumor aggressiveness and metastatic potential. Current assessment of SMAD4 expression relies on IHC of tumor tissue obtained by biopsy or resection, in which limited sampling may not represent intratumoral heterogeneity. T1ρ-weighted imaging, an emerging functional MRI technique, shows promise in characterizing tumor microstructural properties. This study aimed to evaluate the value of T1ρ imaging combined with conventional MRI sequences and clinical parameters for non-invasive prediction of SMAD4 protein expression status in PDAC. Methods: This retrospective single-center study included 57 patients with histologically confirmed PDAC who underwent pretreatment MRI with T1ρ imaging between September 2024 and May 2025. Immunohistochemical analysis revealed SMAD4 intact in 28 tumors (49.1%) and SMAD4 loss in 29 tumors (50.9%). T1ρ values were measured and compared between SMAD4 intact and SMAD4 loss tumors. A multiparametric predictive model incorporating T1ρ values, lymph node metastasis status, and carbohydrate antigen 19-9 (CA19-9) levels was developed. Results: SMAD4 intact tumors demonstrated significantly higher T1ρ values compared to SMAD4 loss tumors (96.34 ± 14.12 vs. 71.93 ± 10.24 ms, p < 0.001). T1ρ achieved an AUC of 0.901 (95% CI: 0.817–0.986), with 82.14% sensitivity and 89.66% specificity, for predicting SMAD4 expression status. A multiparametric model combining T1ρ values, lymph node metastasis status, and CA19-9 levels yielded a numerically higher AUC of 0.932 (95% CI: 0.862–1.000), although the difference from T1ρ alone was not statistically significant (DeLong test, p > 0.05). Conclusions: T1ρ imaging showed potential for predicting SMAD4 status in PDAC.
- Open Access
- 29 September 2026
- Published by Springer Nature in BMC Medical Imaging
Accuracy of 7T high-resolution vessel wall imaging versus CTA in middle cerebral artery stenosis: a DSA-based validation study
- 29 September 2026
- Published by Springer Nature in BMC Medical Imaging
Open AccessAccuracy of 7T high-resolution vessel wall imaging versus CTA in middle cerebral artery stenosis: a DSA-based validation study
- Open Access
- 7 May 2026
- Published by Elsevier in Military Medical Research
- Vol. 13 (1)
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
- 7 May 2026
- Published by Elsevier in Military Medical Research
- Vol. 13 (1)
Open AccessMaladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
- Open Access
- 29 August 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (4) , 1668-1679
Multi-parametric MRI diffusion models combined with clinical information for predicting Ki-67 expression in pancreatic ductal adenocarcinoma: a prospective cohort study
Purpose To evaluate the diagnostic value of intravoxel incoherent motion (IVIM) and diffusion kurtosis imaging (DKI) parameters combined with clinical information for predicting Ki-67 expression in pancreatic ductal adenocarcinoma (PDAC). Methods This prospective cohort study enrolled 65 patients with histopathologically confirmed PDAC between January 2024 and May 2025. All patients underwent 3.0T MRI including conventional sequences and advanced diffusion-weighted imaging sequences. Clinical data and laboratory parameters were collected within one week before surgery or biopsy. Ki-67 expression was assessed using immunohistochemical staining with 50% as the cutoff value. Two radiologists independently performed quantitative measurements with excellent inter-observer reliability (ICC > 0.85). Univariate and multivariate logistic regression analyses identified independent predictors. ROC curve analysis and DeLong test evaluated diagnostic performance. Results Based on Ki-67 expression threshold of 50%, 48 patients (73.8%) were classified as low expression and 17 patients (26.2%) as high expression. Compared to the low Ki-67 group, the high expression group demonstrated significantly lower monocyte count (0.35 ± 0.09 vs. 0.49 ± 0.16 × 10⁹/L, P = 0.001), higher IVIM f-value (14.08 ± 3.41% vs. 10.90 ± 3.83%, P = 0.004), and lower DKI-MD (1.26 ± 0.17 vs. 1.65 ± 0.17 × 10⁻³ mm²/s, P < 0.001). Individual prediction models achieved AUCs of 0.763 (monocyte count), 0.732 (IVIM f-value), and 0.800 (DKI-MD). The combined prediction model integrating these three parameters demonstrated excellent diagnostic performance with AUC of 0.913 (95% CI: 0.841–0.985), sensitivity of 82.4%, and specificity of 83.3%, significantly outperforming all individual models (P < 0.001). Conclusion This multi-parametric combined prediction model achieves excellent diagnostic performance for preoperative non-invasive assessment of Ki-67 expression status in PDAC, providing a reliable tool for precision medicine practice and personalized treatment strategies.
- 29 August 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (4) , 1668-1679
Open AccessMulti-parametric MRI diffusion models combined with clinical information for predicting Ki-67 expression in pancreatic ductal adenocarcinoma: a prospective cohort study
Purpose To evaluate the diagnostic value of intravoxel incoherent motion (IVIM) and diffusion kurtosis imaging (DKI) parameters combined with clinical information for predicting Ki-67 expression in pancreatic ductal adenocarcinoma (PDAC). Methods This prospective cohort study enrolled 65 patients with histopathologically confirmed PDAC between January 2024 and May 2025. All patients underwent 3.0T MRI including conventional sequences and advanced diffusion-weighted imaging sequences. Clinical data and laboratory parameters were collected within one week before surgery or biopsy. Ki-67 expression was assessed using immunohistochemical staining with 50% as the cutoff value. Two radiologists independently performed quantitative measurements with excellent inter-observer reliability (ICC > 0.85). Univariate and multivariate logistic regression analyses identified independent predictors. ROC curve analysis and DeLong test evaluated diagnostic performance. Results Based on Ki-67 expression threshold of 50%, 48 patients (73.8%) were classified as low expression and 17 patients (26.2%) as high expression. Compared to the low Ki-67 group, the high expression group demonstrated significantly lower monocyte count (0.35 ± 0.09 vs. 0.49 ± 0.16 × 10⁹/L, P = 0.001), higher IVIM f-value (14.08 ± 3.41% vs. 10.90 ± 3.83%, P = 0.004), and lower DKI-MD (1.26 ± 0.17 vs. 1.65 ± 0.17 × 10⁻³ mm²/s, P < 0.001). Individual prediction models achieved AUCs of 0.763 (monocyte count), 0.732 (IVIM f-value), and 0.800 (DKI-MD). The combined prediction model integrating these three parameters demonstrated excellent diagnostic performance with AUC of 0.913 (95% CI: 0.841–0.985), sensitivity of 82.4%, and specificity of 83.3%, significantly outperforming all individual models (P < 0.001). Conclusion This multi-parametric combined prediction model achieves excellent diagnostic performance for preoperative non-invasive assessment of Ki-67 expression status in PDAC, providing a reliable tool for precision medicine practice and personalized treatment strategies.